Amol Akhade/hiranandanihospital.org
Jan 23, 2025, 14:32
Amol Akhade: Does CTRT improve outcomes in gall bladder cancer?
Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared the following on X:
“Adjuvant chemo vs. chemo followed by CTRT in gall bladder cancer. Phase 3 RCT from India. Accelerate trial with 94 patients. Post-RO resection: 49 got chemo, 45 got chemo followed by CTRT. Median OS NR vs. 34.56 months. Median RFS 51.96 vs. 43.99 months.
So, the addition of CTRT to chemo alone does not improve outcomes in resected gall bladder cancer. What are your thoughts on this? A small trial, affected by the COVID pandemic, but probably with the right conclusion.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 23, 2025, 11:51
Aug 23, 2025, 11:23
Aug 23, 2025, 11:07
Aug 23, 2025, 10:15
Aug 23, 2025, 09:57
Aug 23, 2025, 09:34
Aug 23, 2025, 08:21